Severe aplastic anemia

There are 4 papers on severe aplastic anemia in aging research: 3 observational studies in people, 1 in animals.

Disease

4 papers study it4 more mention it6 findings

See all 8 papers on severe aplastic anemia

  • Humans3
  • Animals1

Effects

5

Cellular senescence

upin human cells1upin mice1

2 studies
  1. Severe aplastic anemia increases cellular senescence in SAA MSCs vs controls.

    Cellsin SAA MSCs vs controlsbone marrow mesenchymal stem cells

  2. Severe aplastic anemia increases cellular senescence in mice (SAA mouse model induced by IFN-γ and busulfan) (75±11% vs 28±8% SA-β-gal positive cells).

    AnimalsSAA mouse model induced by IFN-γ and busulfanbone marrow-derived mesenchymal stem cells

More on Cellular senescence

IGFBP1

upin human cells1

1 study
  1. Severe aplastic anemia increases IGFBP1 in SAA MSCs vs controls.

    Cellsin SAA MSCs vs controlsbone marrow mesenchymal stem cells

More on IGFBP1

TXNIP

upin human cells1

1 study
  1. Severe aplastic anemia increases TXNIP in SAA MSCs vs controls.

    Cellsin SAA MSCs vs controlsbone marrow mesenchymal stem cells

More on TXNIP

mTOR protein expression

upin mice1

1 study
  1. Severe aplastic anemia increases mTOR protein expression in mice (SAA mouse model induced by IFN-γ and busulfan).

    AnimalsSAA mouse model induced by IFN-γ and busulfanbone marrow-derived mesenchymal stem cells

More on mTOR protein expression

Cell proliferation

downin mice1

1 study
  1. Severe aplastic anemia decreases cell proliferation in mice (SAA mouse model induced by IFN-γ and busulfan) (G0/G1 phase 77.461±1.567% vs 46.045±2.055%).

    AnimalsSAA mouse model induced by IFN-γ and busulfanbone marrow-derived mesenchymal stem cells

Trial sponsors

Funding

1 grant since 2022

National Heart, Lung, and Blood Institute$692K

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months